Intellia Therapeutics Investor
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.
Technology:
Cell-based gene therapy, Cell_Therapies
Industry:
Gene therapy, Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2014-01-01
Employees Number:
501-1000
Funding Status:
IPO
Number Of Exits:
-
Investors Number:
9
Total Funding:
1225000030
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-11-30
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership